Begin with the Exit in Mind
Charles W. Hewitt, Ph.D. has over 30 years of senior management experience in biomedical, pharmaceutical, biotechnology, and health care markets. He was Co-founder and CEO of BioFX Laboratories, raising private placement funding and launching more than 800 novel bioregeants prior to its sale to Surmodics. He holds a Ph.D. in Pathology/Immunology from USC Medical School and a BS in Biochemistry from UC Riverside.
Charles W. Hewitt, Ph.D.

Charles W. Hewitt, Ph.D. has over 30 years of senior management experience in biomedical, pharmaceutical, biotechnology, and health care markets. He was Co-founder and CEO of BioFX Laboratories, raising private placement funding and launching more than 800 novel bioregeants prior to its sale to Surmodics.  He was also CEO of Edge 3D-Imaging, Executive Vice President and Chief Scientific Officer at Epix Pharmaceutical. He has particular proficiency in strategic planning, technology transfer, business development, marketing, clinical trials, R&D collaborative arrangements, licensing, intellectual property and media relations.  His areas of interest include targeted therapeutic drug systems, tissue transplantation and immunosuppression, microscopy and imaging, and in vitro diagnostics.  He holds a Ph.D. in Pathology/Immunology from USC Medical School and a BS in Biochemistry from UC Riverside.





Back to Team Page